Under the agreement, MB Innovations will initially provide design and development expertise in support of the development of MicroPort Orthopedics’ portfolio of instruments and instrument systems associated with its Fast Recovery, tissue-sparing approach to hip arthroplasty procedures.
Additionally, development programs may be initiated for developing other differentiated implants and instruments that are used for both hip and knee arthroplasty procedures during the term of the development agreement.
MicroPort Orthopedics CEO Ted Davis said that the company has already identified the initial programs that leverage its ongoing efforts at innovative, tissue friendly arthroplasty techniques.
"I am confident that MBI will accelerate the pace at which we execute on our mission of delivering important and highly differentiated technologies to help surgeons care for their patients," Davis added.
Image: MicroPort corporate headquarters. Photo: Courtesy of MicroPort Scientific Corporation
